Suppr超能文献

中枢胆碱能机制在对脑室内和静脉注射促甲状腺激素释放激素的心血管反应中的作用。

The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.

作者信息

Okuda C, Mizobe T, Miyazaki M

出版信息

Life Sci. 1987 Mar 30;40(13):1293-9. doi: 10.1016/0024-3205(87)90586-8.

Abstract

Intracerebroventricular (i.c.v.) administration of thyrotropin-releasing hormone (TRH) in a range from 0.1 to 100 micrograms induced a dose-related increase in blood pressure in conscious rats, whereas TRH-free acid (TRH-OH) and histidyl-proline diketopiperazine (His-Pro-DKP), metabolites of TRH, did not. The blood pressure responses to intravenous (i.v.) injection of 5 mg/Kg TRH were similar to those induced by TRH (i.c.v.). Pretreatment with atropine (50 micrograms, i.c.v.) significantly reduced the pressor effect of TRH administered through either route. Hemicholinium-3 (50 micrograms, i.c.v.), an inhibitor of choline uptake, also prevented the increase in blood pressure induced by TRH (10 micrograms, i.c.v.). These results indicate that both centrally and peripherally administered TRH have pressor effects that are mediated by central cholinergic mechanisms, probably by activating cholinergic neurons.

摘要

向清醒大鼠脑室内(i.c.v.)注射0.1至100微克促甲状腺激素释放激素(TRH)可引起血压呈剂量相关的升高,而TRH的代谢产物游离酸TRH(TRH-OH)和组氨酰-脯氨酸二酮哌嗪(His-Pro-DKP)则不会。静脉内(i.v.)注射5毫克/千克TRH引起的血压反应与脑室内注射TRH所诱导的反应相似。用阿托品(50微克,脑室内注射)预处理可显著降低通过两种途径给药的TRH的升压作用。胆碱摄取抑制剂半胱氨酰胆碱-3(50微克,脑室内注射)也可防止TRH(10微克,脑室内注射)引起的血压升高。这些结果表明,中枢和外周给药的TRH均具有升压作用,其通过中枢胆碱能机制介导,可能是通过激活胆碱能神经元实现的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验